ClinicalTrials.gov · NCT06249620 · Completed
Oral Supplementation With AM3, Hesperidin and Spermidine Supplementation on Immunity Response and Biological Age.
Registry record
NCT06249620 on ClinicalTrials.gov. The registry's last update to this record was 8 February 2024.
Verification record
5 checked · 0 company says · 0 reported · 0 not found · 0 not yet checked
- Title as registered Oral Supplementation With AM3, Hesperidin and Spermidine Supplementation on Immunity Response and Biological Age. Checked Source clinicaltrials.gov Brief title as registered. Checked
- Sponsor Industrial Farmacéutica Cantabria, S.A. Checked Source clinicaltrials.gov Lead sponsor as registered. Checked
- Intervention Inmunoferon; Placebo Checked Source clinicaltrials.gov Intervention names as registered. Checked
- Primary outcome as registered Change in Biological Age Checked Source clinicaltrials.gov Primary outcome measure(s) as registered. Checked
- Status Completed Checked Source clinicaltrials.gov Overall status as registered; registry last update 2024-02-08. Checked
Check history: NCT06249620 was last read on the registry on November 14, 2026. No earlier checks are recorded. How records are checked.
Corrections: none recorded for this trial. To ask for one, write to [email protected] with the registry number; every correction is checked against the registry record before the record changes.
As registered
- Sponsor: Industrial Farmacéutica Cantabria, S.A.
- Phase: Not applicable
- Status: Completed
- Intervention: Inmunoferon; Placebo
- Primary outcome: Change in Biological Age
- Countries: Spain
- Start: 19 April 2022
- Completion (actual): 1 October 2022
Results
No results were posted on the registry on the date checked. The Atlas does not summarize findings.